The Huntington National Bank invests in athenahealth Inc. (ATHN) Shares

The Huntington National Bank invests in athenahealth Inc. (ATHN) Shares

Huntington National Bank raised its stake in shares of athenahealth Inc. (NASDAQ:ATHN) by 10.6% during the second quarter, Holdings Channel reports. The institutional investor owned 52,069 shares of the company’s stock after buying an additional 5,005 shares during the period. Huntington National Bank’s holdings in athenahealth were worth $7,187,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in ATHN. Geode Capital Management LLC raised its stake in shares of athenahealth by 4.6% in the first quarter. Geode Capital Management LLC now owns 245,893 shares of the company’s stock valued at $34,125,000 after buying an additional 10,803 shares in the last quarter. State Street Corp raised its stake in shares of athenahealth by 3.2% in the first quarter. State Street Corp now owns 457,047 shares of the company’s stock valued at $63,430,000 after buying an additional 14,099 shares in the last quarter. Pitcairn Co. raised its stake in shares of athenahealth by 7.7% in the second quarter. Pitcairn Co. now owns 3,094 shares of the company’s stock valued at $427,000 after buying an additional 221 shares in the last quarter. Riverhead Capital Management LLC acquired a new stake in shares of athenahealth during the first quarter valued at about $984,000. Finally, Loomis Sayles & Co. L P acquired a new stake in shares of athenahealth during the first quarter valued at about $1,871,000.

Shares of athenahealth Inc. (NASDAQ:ATHN) traded down 0.75% during trading on Thursday, reaching $126.34. The company’s stock had a trading volume of 321,313 shares. athenahealth Inc. has a 12-month low of $114.59 and a 12-month high of $170.42. The company has a 50 day moving average of $123.62 and a 200-day moving average of $129.75. The stock has a market cap of $4.97 billion, a price-to-earnings ratio of 464.49 and a beta of 1.28.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings results on Thursday, July 21st. The company reported $0.34 EPS for the quarter, missing analysts’ consensus estimates of $0.42 by $0.08. athenahealth had a net margin of 1.06% and a return on equity of 5.16%. The firm had revenue of $261.90 million for the quarter, compared to the consensus estimate of $274.07 million. Analysts forecast that athenahealth Inc. will post $1.77 EPS for the current year.

ATHN has been the subject of several research analyst reports. Zacks Investment Research lowered athenahealth from a “hold” rating to a “sell” rating in a research report on Friday, July 29th. Stifel Nicolaus began coverage on athenahealth in a report on Wednesday, August 31st. They issued a “hold” rating for the company. Evercore ISI raised athenahealth from a “hold” rating to a “buy” rating and set a $152.00 price objective for the company in a report on Monday. Leerink Swann reissued a “hold” rating on shares of athenahealth in a report on Thursday, June 16th. Finally, FBR & Co decreased their price objective on athenahealth from $145.00 to $140.00 and set a “market perform” rating for the company in a report on Friday, July 22nd. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the stock. athenahealth presently has a consensus rating of “Hold” and an average target price of $149.70.

In other news, Director John A. Kane sold 2,875 shares of the firm’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $128.81, for a total value of $370,328.75. Following the completion of the sale, the director now directly owns 10,708 shares of the company’s stock, valued at approximately $1,379,297.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Bradford Kyle Armbrester sold 2,545 shares of the firm’s stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $130.00, for a total value of $330,850.00. The disclosure for this sale can be found here. Corporate insiders own 3.04% of the company’s stock.

About athenahealth

athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.

Related posts

Leave a Comment